Pharmaceutical compositions containing an hiv integrase inhibitor and a nonionic surfactant
Pharmaceutical compositions comprise a therapeutically effective amount of an 8-hydroxy-1,6-naphthyridine-7-carboxamide of Formula (I), or a pharmaceutically acceptable salt thereof: and a nonionic surfactant; wherein R1, R2, R3 and Q1 are defined herein. Compounds of Formula (I) are HIV integrase i...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ROBERTSON SANDRA K OSTOVIC DRAZEN KARABORNI SAMI PANMAI SANTIPHARP KAMALI ASHKAN FU XI-YONG CRUANES MARIA T |
| description | Pharmaceutical compositions comprise a therapeutically effective amount of an 8-hydroxy-1,6-naphthyridine-7-carboxamide of Formula (I), or a pharmaceutically acceptable salt thereof: and a nonionic surfactant; wherein R1, R2, R3 and Q1 are defined herein. Compounds of Formula (I) are HIV integrase inhibitors, and the pharmaceutical compositions are useful for preventing or treating HIV infection or for preventing, treating, or delaying the onset of AIDS. The pharmaceutical compositions are typically administered orally, for example, in the form of capsules or tablets, and can provide good oral bioavailability. Methods for preparing encapsulated and tabletted forms of the pharmaceutical compositions are described. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2005165000A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2005165000A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2005165000A13</originalsourceid><addsrcrecordid>eNqNjbEKwkAQRNNYiPoPC9bCRYm9iGIpqJVFWM9NbiHZPe42fr9X-AFWM8ObYebV8xowjehpMvY4gNcxamZjlVyCGLKw9IACgT_AYtQnzFRc4BebpoLegCAqZcMe8pQ69IZiy2rW4ZBp9dNFtT6f7sfLhqK2lGN5FbL2cds619T7xjl3qHf_tb7WiT0c</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Pharmaceutical compositions containing an hiv integrase inhibitor and a nonionic surfactant</title><source>esp@cenet</source><creator>ROBERTSON SANDRA K ; OSTOVIC DRAZEN ; KARABORNI SAMI ; PANMAI SANTIPHARP ; KAMALI ASHKAN ; FU XI-YONG ; CRUANES MARIA T</creator><creatorcontrib>ROBERTSON SANDRA K ; OSTOVIC DRAZEN ; KARABORNI SAMI ; PANMAI SANTIPHARP ; KAMALI ASHKAN ; FU XI-YONG ; CRUANES MARIA T</creatorcontrib><description>Pharmaceutical compositions comprise a therapeutically effective amount of an 8-hydroxy-1,6-naphthyridine-7-carboxamide of Formula (I), or a pharmaceutically acceptable salt thereof: and a nonionic surfactant; wherein R1, R2, R3 and Q1 are defined herein. Compounds of Formula (I) are HIV integrase inhibitors, and the pharmaceutical compositions are useful for preventing or treating HIV infection or for preventing, treating, or delaying the onset of AIDS. The pharmaceutical compositions are typically administered orally, for example, in the form of capsules or tablets, and can provide good oral bioavailability. Methods for preparing encapsulated and tabletted forms of the pharmaceutical compositions are described.</description><edition>7</edition><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2005</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050728&DB=EPODOC&CC=US&NR=2005165000A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050728&DB=EPODOC&CC=US&NR=2005165000A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ROBERTSON SANDRA K</creatorcontrib><creatorcontrib>OSTOVIC DRAZEN</creatorcontrib><creatorcontrib>KARABORNI SAMI</creatorcontrib><creatorcontrib>PANMAI SANTIPHARP</creatorcontrib><creatorcontrib>KAMALI ASHKAN</creatorcontrib><creatorcontrib>FU XI-YONG</creatorcontrib><creatorcontrib>CRUANES MARIA T</creatorcontrib><title>Pharmaceutical compositions containing an hiv integrase inhibitor and a nonionic surfactant</title><description>Pharmaceutical compositions comprise a therapeutically effective amount of an 8-hydroxy-1,6-naphthyridine-7-carboxamide of Formula (I), or a pharmaceutically acceptable salt thereof: and a nonionic surfactant; wherein R1, R2, R3 and Q1 are defined herein. Compounds of Formula (I) are HIV integrase inhibitors, and the pharmaceutical compositions are useful for preventing or treating HIV infection or for preventing, treating, or delaying the onset of AIDS. The pharmaceutical compositions are typically administered orally, for example, in the form of capsules or tablets, and can provide good oral bioavailability. Methods for preparing encapsulated and tabletted forms of the pharmaceutical compositions are described.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2005</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjbEKwkAQRNNYiPoPC9bCRYm9iGIpqJVFWM9NbiHZPe42fr9X-AFWM8ObYebV8xowjehpMvY4gNcxamZjlVyCGLKw9IACgT_AYtQnzFRc4BebpoLegCAqZcMe8pQ69IZiy2rW4ZBp9dNFtT6f7sfLhqK2lGN5FbL2cds619T7xjl3qHf_tb7WiT0c</recordid><startdate>20050728</startdate><enddate>20050728</enddate><creator>ROBERTSON SANDRA K</creator><creator>OSTOVIC DRAZEN</creator><creator>KARABORNI SAMI</creator><creator>PANMAI SANTIPHARP</creator><creator>KAMALI ASHKAN</creator><creator>FU XI-YONG</creator><creator>CRUANES MARIA T</creator><scope>EVB</scope></search><sort><creationdate>20050728</creationdate><title>Pharmaceutical compositions containing an hiv integrase inhibitor and a nonionic surfactant</title><author>ROBERTSON SANDRA K ; OSTOVIC DRAZEN ; KARABORNI SAMI ; PANMAI SANTIPHARP ; KAMALI ASHKAN ; FU XI-YONG ; CRUANES MARIA T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2005165000A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2005</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ROBERTSON SANDRA K</creatorcontrib><creatorcontrib>OSTOVIC DRAZEN</creatorcontrib><creatorcontrib>KARABORNI SAMI</creatorcontrib><creatorcontrib>PANMAI SANTIPHARP</creatorcontrib><creatorcontrib>KAMALI ASHKAN</creatorcontrib><creatorcontrib>FU XI-YONG</creatorcontrib><creatorcontrib>CRUANES MARIA T</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ROBERTSON SANDRA K</au><au>OSTOVIC DRAZEN</au><au>KARABORNI SAMI</au><au>PANMAI SANTIPHARP</au><au>KAMALI ASHKAN</au><au>FU XI-YONG</au><au>CRUANES MARIA T</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Pharmaceutical compositions containing an hiv integrase inhibitor and a nonionic surfactant</title><date>2005-07-28</date><risdate>2005</risdate><abstract>Pharmaceutical compositions comprise a therapeutically effective amount of an 8-hydroxy-1,6-naphthyridine-7-carboxamide of Formula (I), or a pharmaceutically acceptable salt thereof: and a nonionic surfactant; wherein R1, R2, R3 and Q1 are defined herein. Compounds of Formula (I) are HIV integrase inhibitors, and the pharmaceutical compositions are useful for preventing or treating HIV infection or for preventing, treating, or delaying the onset of AIDS. The pharmaceutical compositions are typically administered orally, for example, in the form of capsules or tablets, and can provide good oral bioavailability. Methods for preparing encapsulated and tabletted forms of the pharmaceutical compositions are described.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2005165000A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Pharmaceutical compositions containing an hiv integrase inhibitor and a nonionic surfactant |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T19%3A47%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ROBERTSON%20SANDRA%20K&rft.date=2005-07-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2005165000A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |